Get the Stockscreener App
4.39
0.00%
0.00
After Hours:
4.39
Trisalus Life Sciences Inc stock is traded at $4.39, with a volume of 64,910.
It is up +0.00% in the last 24 hours and down -8.16% over the past month.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
See More
Previous Close:
$4.39
Open:
$4.38
24h Volume:
64,910
Relative Volume:
0.54
Market Cap:
$218.92M
Revenue:
$15.33M
Net Income/Loss:
$-40.19M
P/E Ratio:
-2.5054
EPS:
-1.7522
Net Cash Flow:
-
1W Performance:
-7.38%
1M Performance:
-8.16%
6M Performance:
-15.58%
1Y Performance:
+5.02%
1-Day Range:
$4.2774
$4.41
1-Week Range:
$4.2501
$4.80
52-Week Range:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Name
Trisalus Life Sciences Inc
Sector
Industry
Phone
415 336 8917
Address
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.39 | 218.92M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
126.36 | 217.27B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.02 | 146.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.03 | 135.31B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
92.20 | 115.51B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.39 | 47.84B | 5.88B | 1.34B | 577.90M | 2.3489 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Initiated | Lake Street | Buy |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-11-24 | Initiated | ROTH MKM | Buy |
| Oct-25-24 | Initiated | Northland Capital | Outperform |
| Sep-16-24 | Initiated | Oppenheimer | Outperform |
| May-30-24 | Initiated | Canaccord Genuity | Buy |
View All
Trisalus Life Sciences Inc Stock (TLSI) Latest News
Is TriSalus Life Sciences Inc. Equity Warrant still worth holding after the dipMarket Trend Review & Free Technical Confirmation Trade Alerts - newser.com
Will TriSalus Life Sciences Inc. stock attract more institutional investorsWeekly Trade Review & Reliable Trade Execution Plans - newser.com
What high frequency data says about TriSalus Life Sciences Inc. Equity Warrant2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com
What machine learning models say about TriSalus Life Sciences Inc.July 2025 Closing Moves & Technical Analysis for Trade Confirmation - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock a safe haven assetLayoff News & Long-Term Growth Stock Strategies - newser.com
TriSalus Life Sciences Inc. Equity Warrant stock volume spike explainedRecession Risk & Weekly Momentum Stock Picks - newser.com
Will TriSalus Life Sciences Inc. stock gain from government policiesJuly 2025 Short Interest & Proven Capital Preservation Methods - newser.com
Is now a turning point for TriSalus Life Sciences Inc. Equity WarrantPortfolio Value Report & Daily Technical Stock Forecast Reports - newser.com
Published on: 2025-11-06 05:42:12 - newser.com
Can TriSalus Life Sciences Inc. Equity Warrant stock beat analyst upgradesQuarterly Market Summary & High Yield Stock Recommendations - fcp.pa.gov.br
Will TriSalus Life Sciences Inc. stock gain from strong economy2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
TriSalus Life Sciences (NASDAQ:TLSI) Shares Down 5.3% – Here’s Why - Defense World
Will breakout in TriSalus Life Sciences Inc. Equity Warrant lead to full recoveryQuarterly Earnings Report & Entry and Exit Point Strategies - newser.com
Does TriSalus Life Sciences Inc. show high probability of rebound2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com
TriSalus Life Sciences (TLSI) Projected to Post Quarterly Earnings on Thursday - Defense World
Is TriSalus Life Sciences Inc. stock a dividend growth opportunityJuly 2025 Trends & Safe Capital Growth Plans - newser.com
Combining price and volume data for TriSalus Life Sciences Inc.Weekly Trade Report & Weekly Breakout Watchlists - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock overvalued by current metricsAnalyst Downgrade & Risk Controlled Daily Plans - newser.com
How TriSalus Life Sciences Inc. stock performs in stagflation2025 Market Overview & Growth Focused Investment Plans - newser.com
Can TriSalus Life Sciences Inc. Equity Warrant stock beat market expectations this quarterTrade Entry Summary & Consistent Profit Focused Trading Strategies - fcp.pa.gov.br
Automated trading signals detected on TriSalus Life Sciences Inc.Bull Run & Expert-Curated Trade Recommendations - newser.com
Real time social sentiment graph for TriSalus Life Sciences Inc.Market Sentiment Review & Accurate Buy Signal Alerts - newser.com
Will TriSalus Life Sciences Inc. Equity Warrant stock reach Wall Street targetsStock Surge & Short-Term Trading Alerts - fcp.pa.gov.br
Will TriSalus Life Sciences Inc. Equity Warrant stock recover after recent drop2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Can TriSalus Life Sciences Inc. Equity Warrant stock surprise with earnings upsideDollar Strength & Daily Entry Point Alerts - fcp.pa.gov.br
Can TriSalus Life Sciences Inc. stock surprise with earnings upsideDollar Strength & Fast Gain Stock Trading Tips - newser.com
Can machine learning forecast TriSalus Life Sciences Inc. Equity Warrant recoveryJuly 2025 Gainers & Community Supported Trade Ideas - newser.com
Published on: 2025-11-05 00:10:13 - newser.com
Has TriSalus Life Sciences Inc. formed a bullish divergencePortfolio Value Report & Reliable Price Breakout Alerts - newser.com
Regression analysis insights on TriSalus Life Sciences Inc. Equity Warrant performanceWeekly Trend Summary & Real-Time Stock Movement Alerts - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock attractive for long term wealth buildingQuarterly Profit Summary & High Accuracy Trade Signal Alerts - newser.com
What high frequency data says about TriSalus Life Sciences Inc.Entry Point & High Return Stock Watch Alerts - newser.com
What’s next for TriSalus Life Sciences Inc. stock price2025 Macro Impact & Free Accurate Trade Setup Notifications - newser.com
Trisalus Life Sciences Inc Stock (TLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.21%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):